Study Evaluating the Safety Feasibility and Efficacy of ODI-2001 Vaccine, a Personnalized Immunotherapy in Patients With Metastatic or Locally Advanced Colon Cancer or Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Locally Advanced Pancreatic Cancer
Related studies linked through entity extraction aliases.
Endoscopic Ultrasound-Guided Loco-regional Chemotherapy Injection as Adjuvant Therapy for Locally Advanced Pancreatic Cancer.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Combined Chemotherapy And Ablative Radiotherapy (SBRT) As First-Line Treatment In Locally Advanced Inoperable Pancreatic Cancer (SBRT-PANC)
- Status
- RECRUITING
- Phase
- NA
Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Stereotactic Centralized Ablative Radiotherapy for Locally Advanced Pancreatic Cancer: A Single-Arm Phase I Safety and Feasibility Study
- Status
- SUSPENDED
- Phase
- PHASE1
A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer
- Status
- RECRUITING
- Phase
- N/A
mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus NALIRIFOX as Conversion Therapy of Locally Advanced Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as First-line Treatment of Locally Advanced Pancreatic Cancer
- Status
- RECRUITING
- Phase
- NA
Nimotuzumab Plus NALIRIFOX in Locally Advanced Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Prophylactic Administration of Neulapeg (Pegteograstim) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Receiving the Modified FOLFIRINOX
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Surufatinib and Serplulimab Combined With AG Regimen Compare With AG Regimen as Conversion Therapy for Patients With Locally Advanced Pancreatic Cancer (SAGE)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial
- Status
- RECRUITING
- Phase
- NA
Clinical Study of Tumor Treating Fields Combined with Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE3
FOLFIRINOX Versus OncoSilâ„¢ in Addition to FOLFIRINOX in Patients With Locally Advanced Pancreatic Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapY
- Status
- COMPLETED
- Phase
- N/A
The Transformation of Locally Advanced Pancreatic Cancer.
- Status
- UNKNOWN
- Phase
- PHASE2